Status:
COMPLETED
Targeted Intervention for Melanoma Prevention
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
American Cancer Society, Inc.
Conditions:
Melanoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, the researchers will conduct interviews with melanoma patients to describe the sun exposure and sun protection practices of patients and their children. The researchers will use the fin...
Detailed Description
Research is to learn about awareness, attitudes, and behaviors related to sun exposure, sun protection, skin examination, and other risk-reducing behaviors. The results of this study will be used to d...
Eligibility Criteria
Inclusion
- Melanoma patients are eligible if they were diagnosed with in situ, localized, or microscopic stage III melanoma after January 1, 1988.
- Melanoma patients are eligible if they are the parent of a child 12 years of age or younger and reside with the child.
- Melanoma patients are eligible if they provide informed consent.
- Melanoma patients are eligible if they are 18 years of age or older.
- Melanoma patients are eligible if they are able to speak, read, and write English.
- Melanoma patients are eligible if they meet all inclusion criteria.
Exclusion
- 1\) Melanoma patients are not eligible if they cannot provide informed consent.
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 26 2019
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT00394134
Start Date
April 1 2005
End Date
August 26 2019
Last Update
September 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030